Bonner Michael Insider Trades

Insider Trading History

Track insider trading activity for Bonner Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $65.7k 11,720 shares
Last Trade
May 17, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$21.2k 7,500 shares
$2.83
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 17, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$14.2k 5,000 shares
$2.83
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $108k 19,220 shares
Last Trade
Mar 17, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.44k 1,067 shares
$3.22
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $28.1k 5,000 shares
Last Trade
Mar 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.1k 5,000 shares
$3.22
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $114k 20,287 shares
Last Trade
Mar 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.9k 2,500 shares
$3.56
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $99.8k 17,787 shares
Last Trade
Mar 18, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.53k 2,134 shares
$3.53
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $118k 20,954 shares
Last Trade
Mar 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15k 2,500 shares
$5.98
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $112k 19,921 shares
Last Trade
Mar 22, 2019 Purchase (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.71k 1,033 shares
$6.50
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $104k 18,454 shares
Last Trade
Aug 29, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$624 100 shares
$6.24
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $103k 18,354 shares
Last Trade
Aug 28, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.78k 300 shares
$5.92
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $101k 18,054 shares
Last Trade
May 17, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.45k 400 shares
$6.12
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $104k 18,497 shares
Last Trade
Mar 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.8k 2,500 shares
$6.70
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $99k 17,654 shares
Last Trade
Mar 23, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.65k 843 shares
$6.70
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $89.7k 15,997 shares
Last Trade
Mar 19, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.02k 300 shares
$6.72
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $88.1k 15,697 shares
Last Trade
Nov 22, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.95k 250 shares
$7.81
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $86.7k 15,447 shares
Last Trade
Aug 23, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.36k 500 shares
$6.72
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $83.9k 14,947 shares
Last Trade
May 31, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.09k 300 shares
$6.95
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $85.8k 15,300 shares
Last Trade
Apr 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.1k 2,500 shares
$6.45
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $82.2k 14,647 shares
Last Trade
Apr 07, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.21k 653 shares
$6.45
$5.61
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals CPIX
Chief Financial Officer
Holding Value $71.8k 12,800 shares
Last Trade
Mar 23, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.78k 900 shares
$6.42
$5.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up